Zdravookhranenie v Rossii. Statisticheskii sbornik (Healthcare in Russia. Statistical Yearbook), Moscow: Rosstat, 2023.

Helander, A., Péter, O., and Zheng, Y., Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment setting, Alcohol Alcohol. (Oxford, U. K.), 2012, vol. 47, no. 5, pp. 552–557. https://doi.org/10.1093/alcalc/ags065

Article  CAS  Google Scholar 

Tawiah, K.D., Riley, S.B., and Budelier, M.M., Biomarkers and clinical laboratory detection of acute and chronic ethanol use, Clin. Chem., 2022, vol. 68, no. 5, pp. 635–645. https://doi.org/10.1093/clinchem/hvac004

Article  PubMed  Google Scholar 

Jones, A.W., Brief history of the alcohol biomarkers CDT, EtG, EtS, 5-HTOL, and Peth, Drug Test. Anal., 2024, vol. 16, no. 6, pp. 570–587. https://doi.org/10.1002/dta.3584

Article  CAS  PubMed  Google Scholar 

Årving, A., Hilberg, T., Vigerust, E.W., et al., Assessing alcohol consumption across phosphatidylethanol levels using HDL-cholesterol as a predictor, Alcohol Alcohol. (Oxford, U. K.), 2024, vol. 60, no. 1, p. agae085. https://doi.org/10.1093/alcalc/agae085

Tarasova, O.I., Mazurchik, N.V., and Ogurtsov, P.P., Diagnostics of chronic alcohol intoxication. Biological markers of alcohol abuse, in Narkologiya: natsional’noe rukovodstvo (Narcology: National Guidelines), Ivanets, N.N., Anokhina, I.P., and Vinnikova, M.A., Eds., Moscow: GEOTAR-Media, 2016, 2nd ed., pp. 856–861.

Årving, A., Høiseth, G., Hilberg, T., et al., Comparison of the diagnostic value of phosphatidylethanol and carbohydrate-deficient transferrin as biomarkers of alcohol consumption, Alcohol., Clin. Exp. Res., 2021, vol. 45, p. 153. https://doi.org/10.1111/acer.14503

Article  CAS  PubMed  Google Scholar 

Helander, A. and Hansson, T., The alcohol biomarker phosphatidylethanol (PEth)—test performance and experiences from routine analysis and external quality assessment, Scand. J. Clin. Lab. Invest., 2023, vol. 83, pp. 424–431. https://doi.org/10.1080/00365513.2023.2253734

Article  CAS  PubMed  Google Scholar 

Koskela, M., Bäck, S., Võikar, V., et al., Update of neurotrophic factors in neurobiology of addiction and future directions, Neurobiol. Dis., 2017, vol. 97, pp. 189–200. https://doi.org/10.1016/j.nbd.2016.05.010

Article  CAS  PubMed  Google Scholar 

Bykov, I.M., Popov, K.A., Lubchenko, D.A., et al., Changes in the content of protein markers referring to the nervous tissue damage in patients with psychoactive substance dependence syndrome, Med. Vestn. Sev. K-avk., 2021, vol. 16, no. 3, pp. 277–280. https://doi.org/10.14300/mnnc.2021.16065

Article  Google Scholar 

Shafiee, A., Jafarabady, K., Rafiei, M.A., et al., Effect of alcohol on Brain-Derived Neurotrophic Factor (BDNF) blood levels: A systematic review and meta-analysis, Sci. Rep., 2023, vol. 13, no. 1, p. 17554. https://doi.org/10.1038/s41598-023-44798-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Malewska-Kasprzak, M., Skibińska, M., and Dmitrzak-Węglarz, M., Alterations in neurotrophins in alcohol-addicted patients during alcohol withdrawal, Brain Sci., 2024, vol. 14, no. 6, p. 583. https://doi.org/10.3390/brainsci14060583

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang, Z., Robinson, L., Whelan, R., et al., Machine learning models for diagnosis and risk prediction in eating disorders, depression, and alcohol use disorder, J. Affective Disord., 2025, vol. 379, pp. 889–899. https://doi.org/10.1016/j.jad.2024.12.053

Article  Google Scholar 

Hoeppner, B.B., Stout, R.L., Jackson, K.M., and Barnett, N.P., How good is fine-grained Timeline Follow-back data? Comparing 30-day TLFB and repeated 7-day TLFB alcohol consumption reports on the person and daily level, Addict. Behav., 2010, vol. 35, no. 12, pp. 1138–1143. https://doi.org/10.1016/j.addbeh.2010.08.013

Article  PubMed  PubMed Central  Google Scholar 

McGinnis, K.A., Tate, J.P., Bryant, K.J., et al., Change in alcohol use based on self-report and a quantitative biomarker, phosphatidylethanol, in people with HIV, AIDS Behav., 2022, vol. 26, no. 3, pp. 786–794. https://doi.org/10.1007/s10461-021-03438-y

Article  PubMed  Google Scholar 

Babor, T.F., Higgins-Biddle, J.C., Saunders, J.B., and Monteiro, M.G., The Alcohol Use Disorders Identification Test, World Health Organization, 2001.

Lange, S., Shield, K., Monteiro, M., and Rehm, J., Facilitating screening and brief interventions in primary care: A systematic review and meta-analysis of the AUDIT as an indicator of alcohol use disorders, Alcohol., Clin. Exp. Res., 2019, vol. 43, no. 10, pp. 2028–2037. https://doi.org/10.1111/acer.14171

Article  PubMed  Google Scholar 

Ornell, F., Scherer, J.N., Schuch, J.B., et al., Serum BDNF levels increase during early drug withdrawal in alcohol and crack cocaine addiction, Alcohol, 2023, vol. 111, pp. 1–7. https://doi.org/10.1016/j.alcohol.2023.04.001

Article  CAS  PubMed  Google Scholar 

Lepeak, L., Miracle, S., Ferragud, A., et al., Pituitary adenylate cyclase-activating polypeptide (PACAP) of the bed nucleus of the stria terminalis mediates heavy alcohol drinking in mice, eNeuro, 2023, vol. 10, no. 12, p. 0424. https://doi.org/10.1523/ENEURO.0424-23.2023

Wei, X., Cai, F., Zhou, S., et al., The neuropeptide Y single-nucleotide polymorphism rs16147:T>C moderates the effect of alcohol dependence on depression in male Chinese Han population, Front. Psychiatry, 2022, vol. 13, p. 1012850. https://doi.org/10.3389/fpsyt.2022.1012850

Article  PubMed  PubMed Central  Google Scholar 

Winterdahl, M., Miani, A., Vercoe, M.J.H., et al., Vulnerability to psychogenic non-epileptic seizures is linked to low neuropeptide Y levels, Stress, 2017, vol 20, no. 6, pp. 589–597. https://doi.org/10.1080/10253890.2017.1378638

Article  CAS  PubMed  Google Scholar 

Angelucci, F., Veverova, K., Katonová, A., et al., Serum PAI-1/BDNF ratio is increased in Alzheimer’s disease and correlates with disease severity, ACS Omega, 2023, vol. 8, no. 39, pp. 36025–36031. https://doi.org/10.1021/acsomega.3c04076

Article  CAS  PubMed  PubMed Central  Google Scholar 

Penadés, R., López-Vílchez, I., Catalán, R., et al., BDNF as a marker of response to cognitive remediation in patients with schizophrenia: A randomized and controlled trial, Schizophr. Res., 2018, vol. 197, pp. 458–464. https://doi.org/10.1016/j.schres.2017.12.002

Article  CAS  PubMed  Google Scholar